| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-42 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
1990-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1995-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dc052f7a59ee8e44a59661e6f4f4e9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85d26843ce31481e617ad5cacb7c3824
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_768a91af8ede88fdcb50d4743aa54803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_281db9a4dad5e4b5d9090c231309d2fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc5a89faae972cf04f5d9fb85eba6de2 |
| publicationDate |
1995-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2048469-C1 |
| titleOfInvention |
Method of synthesis of azetidine derivative or its pharmaceutical acceptable salt |
| abstract |
FIELD: organic chemistry. SUBSTANCE: product: azetidine derivative of the formula (I) with definite radical values. Reagent 1: compound of the formula (I) where R 3 -H. Reagent 2: compound of the formula R 3 -X, where R 3 as indicated above, X halogen atom. Reaction conditions: conversion of the group R 3 if necessary to any other meaning of the group R 3 . Synthesized compounds were used as antiallergic and antiasthmatic drugs. EFFECT: improved method of synthesis. 2 tbl |
| priorityDate |
1989-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |